These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3834163)

  • 1. [High dose cytosine arabinoside (HDCA) in children with refractory leukemia or malignant lymphoma (3 g/m2 vs 1.5 g/m2)].
    Yumura K; Kawa K; Ishihara S; Hara J; Doi S; Tomita K; Yabuuchi H
    Rinsho Ketsueki; 1985 Dec; 26(12):1979-85. PubMed ID: 3834163
    [No Abstract]   [Full Text] [Related]  

  • 2. [High-dose cytosine arabinoside administration in the treatment of refractory leukemia].
    Yoshida M; Furukawa Y; Akashi M; Komatsu N; Takeda K; Muroi K; Ikeda K; Ohsaka A; Ohta M; Suda K
    Rinsho Ketsueki; 1985 Aug; 26(8):1258-64. PubMed ID: 3865002
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
    Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
    Esumi N; Todo S; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical pharmacology of cytosine arabinoside.
    Slevin ML; Piall EM; Aherne GW; Johnston A; Lister TA
    Haematol Blood Transfus; 1983; 28():70-5. PubMed ID: 6862311
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of refractory leukemia with high-dose cytosine arabinoside.
    Klener P; Háber J
    Neoplasma; 1985; 32(1):113-7. PubMed ID: 3856754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High-dose cytosine arabinoside in acute leukemia: a cooperative study].
    Urabe A; Takaku F; Mizoguchi H; Yamada O; Wakabayashi Y; Miura Y; Sakamoto S; Yoshida M; Miwa S; Asano S
    Rinsho Ketsueki; 1985 Feb; 26(2):184-8. PubMed ID: 3894715
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I trial of cytarabine and hydroxyurea.
    Pfeifle CE; Howell SB
    Cancer Treat Rep; 1983 Dec; 67(12):1127-9. PubMed ID: 6652629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytosine-arabinoside in the treatment of acute leukemias].
    Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
    Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
    [No Abstract]   [Full Text] [Related]  

  • 11. [High-dose cytosine arabinoside therapy in refractory acute leukemia].
    Yorimitsu S; Takahashi I; Kitazima K; Kimura I; Hara M; Tokuda M
    Rinsho Ketsueki; 1984 Dec; 25(12):1941-6. PubMed ID: 6533329
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse.
    Jones GR; Ettinger LJ
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):150-4. PubMed ID: 3874431
    [No Abstract]   [Full Text] [Related]  

  • 13. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
    Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
    Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
    [No Abstract]   [Full Text] [Related]  

  • 14. A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of Rome.
    Testi AM; Moleti ML; Giona F; Annino L; Chiaretti S; Del Giudice I; Todisco E; D'Elia G; Ferrari A; Arcese W; Mandelli F
    Haematologica; 1997; 82(5 Suppl):19-22. PubMed ID: 9402749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar toxicity with high-dose cytosine arabinoside.
    Herzig RH; Hines JD; Herzig GP; Wolff SN; Cassileth PA; Lazarus HM; Adelstein DJ; Brown RA; Coccia PF; Strandjord S
    J Clin Oncol; 1987 Jun; 5(6):927-32. PubMed ID: 3585447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosine arabinoside (NSC-63878) given subcutaneously to patients with cancer.
    Savel H; Burns SL
    Cancer Chemother Rep; 1969 Apr; 53(2):153-6. PubMed ID: 5799419
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of refractory acute leukemia with high-dose cytosine arabinoside.
    Liu MC; Chen YC; Tsay W; Shen MC; Wang CH; Liu CH
    Taiwan Yi Xue Hui Za Zhi; 1987 Jun; 86(6):628-33. PubMed ID: 3655707
    [No Abstract]   [Full Text] [Related]  

  • 18. A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University "La Sapienza" of Rome.
    Testi AM; Moleti ML; Giona F; Annino L; Chiaretti S; Del Giudice I; Todisco E; D'Elia G; Ferrari A; Arcese W; Mandelli F
    Haematologica; 1997; 82(6):664-7. PubMed ID: 9499665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination chemotherapy with cytosine arabinoside and daunomycin in childhood acute leukemia].
    Tsukimoto I; Mimaya J; Toyosaka H; Nagao T; Hanawa Y
    Rinsho Ketsueki; 1973 May; 14(5):596-603. PubMed ID: 4738276
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of cytosine arabinoside on cell kinetics in adult acute leukemia and its correlation to the therapeutic response].
    Furusawa S; Adachi Y; Nomura T; Komiya M
    Rinsho Ketsueki; 1972 Dec; 13(6):943-50. PubMed ID: 4675065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.